Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3351044
Max Phase: Preclinical
Molecular Formula: C55H68N12O12S2
Molecular Weight: 1153.35
Molecule Type: Small molecule
Associated Items:
ID: ALA3351044
Max Phase: Preclinical
Molecular Formula: C55H68N12O12S2
Molecular Weight: 1153.35
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NN(C(=O)N(C)C(=O)c2ccccc2)[C@@H](O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)O)NC(=O)[C@H](Cc2ccccc2)NC1=O
Standard InChI: InChI=1S/C55H68N12O12S2/c1-32(68)45-51(74)61-41(26-33-16-6-3-7-17-33)48(71)62-44(53(76)77)31-81-80-30-38(57)46(69)60-42(27-34-18-8-4-9-19-34)49(72)64-54(78)67(55(79)66(2)52(75)35-20-10-5-11-21-35)65-43(28-36-29-58-39-23-13-12-22-37(36)39)50(73)59-40(47(70)63-45)24-14-15-25-56/h3-13,16-23,29,32,38,40-45,54,58,65,68,78H,14-15,24-28,30-31,56-57H2,1-2H3,(H,59,73)(H,60,69)(H,61,74)(H,62,71)(H,63,70)(H,64,72)(H,76,77)/t32-,38+,40+,41+,42+,43+,44+,45+,54+/m1/s1
Standard InChI Key: SQPLVZLTUHGUDH-SMKJQIFISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1153.35 | Molecular Weight (Monoisotopic): 1152.4521 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Rivier J, Erchegyi J, Hoeger C, Miller C, Low W, Wenger S, Waser B, Schaer JC, Reubi JC.. (2003) Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan., 46 (26): [PMID:14667212] [10.1021/jm030243c] |
Source(1):